Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Targeted Therapy Combined with Immunotherapy as Neoadjuvant Treatment for Locally Advanced Differentiated Thyroid Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Huang N, Wei W, Xiang J, et al. The efficacy and safety of anlotinib in neoadjuvant treatment of locally advanced thyroid cancer: a single-arm phase II clinical trial. Thyroid. 2021;31:1808–13.

    Article  CAS  PubMed  Google Scholar 

  2. Chen J, Huang N, Wei W, et al. The efficacy and safety of surufatinib combined with anti PD-1 antibody toripalimab in neoadjuvant treatment of locally advanced differentiated thyroid cancer: a phase II study. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14031-z.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China

    Jia-ying Chen MD, PhD, Yu-long Wang MD, PhD, Yu Wang MD & Qing-hai Ji MD

  2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    Jia-ying Chen MD, PhD, Yu-long Wang MD, PhD, Yu Wang MD & Qing-hai Ji MD

Authors
  1. Jia-ying Chen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-long Wang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qing-hai Ji MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jia-ying Chen MD, PhD.

Ethics declarations

Disclosure

No competing financial interests exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Jy., Wang, Yl., Wang, Y. et al. ASO Author Reflections: Targeted Therapy Combined with Immunotherapy as Neoadjuvant Treatment for Locally Advanced Differentiated Thyroid Cancer. Ann Surg Oncol 30, 7183–7184 (2023). https://doi.org/10.1245/s10434-023-14063-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14063-5

Search

Navigation